Site-agnostic PARP-inhibitor maintenance therapy of advanced stage BRCA2-mutated gastric-type endocervical adenocarcinoma: A case report
Lauren Jill Tostrud,
Sahana Somasegar,
Malte Renz
Affiliations
Lauren Jill Tostrud
Department of Obstetrics & Gynecology, Stanford University School of Medicine, Palo Alto, CA, United States
Sahana Somasegar
Gynecologic Oncology Division, Stanford University School of Medicine, Palo Alto, CA, United States
Malte Renz
Stanford University, Stanford, CA, United States; Department of Obstetrics & Gynecology, Heinrich-Heine University Düsseldorf, Germany; Corresponding author at: Moorenstrasse 5, 40225 Düsseldorf, Germany.
